To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis. mfm [Internet]. 2024 May 2 [cited 2025 Dec. 26];30(9). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/3872